KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $51.6 million.

  • Exact Sciences' Share-based Compensation rose 587.81% to $51.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $211.2 million, marking a year-over-year decrease of 581.11%. This contributed to the annual value of $214.9 million for FY2024, which is 710.17% down from last year.
  • Exact Sciences' Share-based Compensation amounted to $51.6 million in Q3 2025, which was up 587.81% from $55.8 million recorded in Q2 2025.
  • Over the past 5 years, Exact Sciences' Share-based Compensation peaked at $77.3 million during Q1 2021, and registered a low of $45.9 million during Q4 2022.
  • Moreover, its 5-year median value for Share-based Compensation was $55.9 million (2021), whereas its average is $56.2 million.
  • As far as peak fluctuations go, Exact Sciences' Share-based Compensation skyrocketed by 16147.5% in 2021, and later crashed by 3215.21% in 2022.
  • Exact Sciences' Share-based Compensation (Quarter) stood at $55.9 million in 2021, then decreased by 17.83% to $45.9 million in 2022, then rose by 27.57% to $58.6 million in 2023, then fell by 16.0% to $49.2 million in 2024, then rose by 4.92% to $51.6 million in 2025.
  • Its Share-based Compensation stands at $51.6 million for Q3 2025, versus $55.8 million for Q2 2025 and $54.6 million for Q1 2025.